Price: 7.0

Today's Change: 0.0

Today's Percent Change: -3.89%

Today's Volume: 106

Average Daily Volume: 10123

52 week low: 4.76

52 week high: 7.96

Market cap: 35340000.0

EBITDA: 1650000.0

EBITDA / market_cap: 4.67%

Earnings per Share (EPS): 0.09

EPS / price: 1.29%

Dividend Yield: 0.0%

Dividend per share: 0.0

Book value: 4.16

Price to Book Ratio: 1.68

Price to Earnings (P/E) Ratio: 80.46

Price to Earnings Growth (PEG) Ratio: 0.0

Price to Sales (P/S) Ratio: 3.73

Short Ratio: 5.24

Exchange: "NCM"

Short term: UP (Previous: UP)

Mid term: UP (Previous: UP)

Long term: UP (Previous: UP)

Support: 5.52

Resistance: 5.67

Pivot point: 5.60

SMA 10: 5.47

SMA 50: 5.50

SMA 100: 5.73

RSI 10: 59.03

RSI 50: 48.87

RSI 100: 48.68

EMA 10: 5.46

EMA 50: 5.53

EMA 100: 5.80

STRONG BUY

Based on 12 buy signals and 0 sell signals

Previous signal: strong buy

5.69

NEGATIVE

ICCC
ICCC

@WeekHerald: Analyzing ImmuCell $ICCC & Vermillion $VRML https://t.co/WLGJz1V2TR

@dispatchtribune: Head-To-Head Comparison: Vermillion $VRML versus ImmuCell $ICCC https://t.co/U6hlNP45Oi

@hareng_rouge: "Tri-Shield: we’re just gaining great traction with that product. And the more we produce, the more we sell. I mean… https://t.co/Z2KZ4g1E5u

@bulletin_en: Reviewing XBiotech Inc. $ICCC's results https://t.co/QKD8M3uI4F

@TickerReport: Contrasting ImmuCell $ICCC & Celldex Therapeutics $CLDX https://t.co/46FRmJujIc

@dispatchtribune: ImmuCell $ICCC Issues Earnings Results https://t.co/Un6Hxqijaq

@bulletin_en: Contrasting of Aytu BioScience Inc. $ICCC https://t.co/Nr4V3URUQm

@SiteFocusHQ: $ICCC Qualitative Analysis of recent earnings identified ImmuCell Corporation (NASDAQ: ICCC ) business focus on (co… https://t.co/XMVs2P81hA

@NewsToDesk: $ICCC: ImmuCell Corporation’s (ICCC) CEO Michael Brigham on Q1 2019 …: https://t.co/i2bh0eiwzE